Stock Market News
With relationships spanning 600 telecommunications operators, a potential reach of 2.3 billion end users, and fresh momentum in mobile entertainment, IQSTEL is advancing its strategy to transform a substantial telecommunications platform into a higher-mar
NRXP Reports Three Successfully Manufactured Commercial Lots, Two-Year Stability Data, and Commercially Releasable Supply Pending FDA Approval — While an $11.18 Million DARPA Contract Expands the Company's Research Opportunities
October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential
New SmallCapVoice interview with $SKYQ puts the spotlight on a restarted Nevada refinery, 5,000-barrel-per-day potential, a non-dilutive $50 million oil-development initiative and Sky Quarry's plans to ramp both Nevada and Utah operations.
Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline
As fentanyl continues to drive an enormous public-health challenge in the United States, Nutriband's AVERSA™ technology is being developed to address a different but important piece of the problem: abuse, misuse, diversion and accidental exposure involvin
Cycurion, Inc. (N A S D A Q: CYCU) Expands From Government Cybersecurity Into Public Safety, Healthcare, AI, Fleet Analytics and Commercial Markets as Q2 Margins Surge Nearly 5X and Management Authorizes $500K Share Repurchases
Today's air-permit approval and immediate Eagle Springs restart mark a major operational milestone, while 5,000-barrel-per-day capacity, 15,000 barrels of crude inventory, Nevada oil-development plans and a tightening Western refining market put Sky Quarr
$NTRB reaches a new 52-week high of $9.00 and closes at $8.99, extending a powerful September advance as the company approaches the September 30 expiration of 910,904 publicly traded warrants and continues advancing its AVERSA™ abuse-deterrent transdermal
Today's Proposed Combination Could Significantly Expand CDIX's Healthcare Footprint — While New Equity, Warrants and Exercise Activity Put the Capital Structure Squarely in Focus
New worldwide agreement adds human cellular validation to Lunai's AI-driven Parkinson's platform, creating a potential path from patient subtypes and biomarkers to biological mechanisms and therapeutic targets. Positioned for $400M to $1.2 Billion US Coun
With $NTRB shares gaining significant momentum in September, investors are watching a rapidly approaching warrant expiration, new intellectual-property progress for Nutriband's abuse-deterrent fentanyl platform, strengthening visibility through Nasdaq's b
With a potential Q4 commercial launch, expanding diagnostic opportunities, a major telehealth platform, veterinary oncology initiatives and a proposed Xycota acquisition, NexTel is positioning $MAJI around multiple potential growth catalysts
Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform, while HOPE Therapeutics advances robotic TMS deployment and the company's preservative-free ketamine program moves closer to commercializ
With its Nevada refinery preparing to return to production, a potentially transformative $50 million oil-development initiative underway and innovative resource-recovery technology in its portfolio, Sky Quarry $SKYQ is positioning itself for an exciting p
Strategic Appointments Bring Decades of U.S. Military and Government Experience to (NAS DAQ: ASTI) $ASTI as NASA-Related Testing, MEO/GEO Qualification, Spacecraft Deployments, Drones, HAPS and Autonomous Systems Expand the Company's Commercial Opportunit
~$30 Million Revenue Run Rate, 800+ New Public-Safety Customers, New Patents and $500,000 Share Repurchase Program Highlight a Dramatic 2026 Transformation
Cycurion, Inc. (NAS DAQ: CYCU) $CYCU Recently Announced a $500,000 Share Repurchase Plan Plus US Patent Protection Extended on Vital Technology for Wide Ranging Security Platforms.
With NASA testing demonstrating potential radiation self-annealing in ASTI's CIGS technology, the Company is now expanding its validation program beyond Low Earth Orbit as demand grows for lightweight, resilient solar solutions for space-based power, orbi
Affluence Corporation (Stock Symbol: AFFU) $AFFU Delivers AI-Enabled IoT, 5G and Data Visualization Platform;s to Enterprise and Municipal Clients Worldwide
MBody AI Corp / Check-Cap Ltd. (NAS DAQ: MBAI) $MBAI Operates in the $16 Billion 2026 North American Service Robotics Market Projected to Reach $29 Billion by 2031